This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its unique spirocyclic structure makes it valuable in the development of compounds targeting the central nervous system (CNS). Specifically, it is employed in the creation of drugs designed to treat neurological disorders such as anxiety, depression, and schizophrenia. Additionally, its structural properties are explored in the design of molecules with potential anti-inflammatory and analgesic effects. Researchers also investigate its use in the development of novel ligands for receptor binding studies, aiding in the discovery of new drug candidates.